This inventor holds 1 USPTO granted patent. Top assignees: Esteve Pharmaceuticals, S.a., Universität Autonoma De Barcelona. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 34 
1 out of 49 
Years Active: 2025
Title: Maria Molas-Laplana: Innovator in Recombinant Viral Vectors
Introduction
Maria Molas-Laplana is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of gene therapy through her innovative methods for producing recombinant viral vectors. Her work is particularly focused on recombinant AAV vectors, which are crucial for effective gene therapy applications.
Latest Patents
Maria holds a patent for "Methods for the manufacture of recombinant viral vectors." This invention relates to the production of high titer recombinant viral vectors, enabling the methods to be effectively employed on a scale suitable for practical gene therapy techniques. She has 1 patent to her name, showcasing her expertise in this specialized area.
Career Highlights
Throughout her career, Maria has worked with esteemed organizations such as Esteve Pharmaceuticals and Universitat Autònoma de Barcelona. Her experience in these institutions has allowed her to develop and refine her innovative techniques in the field of biotechnology.
Collaborations
Maria has collaborated with notable colleagues, including Francesc Godia-Casablancas and Maria-Fàtima Bosch-Tubert. These partnerships have further enhanced her research and development efforts in recombinant viral vectors.
Conclusion
Maria Molas-Laplana is a key figure in the advancement of gene therapy through her innovative work on recombinant viral vectors. Her contributions are paving the way for future developments in this critical area of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile